BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37787446)

  • 1. The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role.
    Han J; Itoh T; Shioya A; Sakurai M; Oyama T; Kumagai M; Takamura H; Okuro M; Mukai T; Kitakata H; Inagaki M; Higashi M; Guo X; Yamada S
    Histol Histopathol; 2023 Dec; 38(12):1415-1427. PubMed ID: 37787446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.
    Shioya A; Guo X; Motono N; Mizuguchi S; Kurose N; Nakada S; Aikawa A; Ikeda Y; Uramoto H; Yamada S
    Int J Med Sci; 2018; 15(10):1025-1034. PubMed ID: 30013444
    [No Abstract]   [Full Text] [Related]  

  • 3. Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysis.
    Hashimoto Y; Ishida M; Ryota H; Yamamoto T; Kosaka H; Hirooka S; Yamaki S; Kotsuka M; Matsui Y; Yanagimoto H; Tsuta K; Satoi S
    Pancreatology; 2019 Apr; 19(3):443-448. PubMed ID: 30879968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4.
    Jain P; Dvorkin-Gheva A; Mollen E; Malbeteau L; Xie M; Jessa F; Dhavarasa P; Chung S; Brown KR; Jang GH; Vora P; Notta F; Moffat J; Hedley D; Boutros PC; Wouters BG; Koritzinsky M
    Sci Adv; 2021 May; 7(19):. PubMed ID: 33962950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
    Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
    Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
    Song Y; Tang MY; Chen W; Wang Z; Wang SL
    Dis Markers; 2020; 2020():7656031. PubMed ID: 33029256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.
    Takeda T; Izumi H; Kitada S; Uramoto H; Tasaki T; Zhi L; Guo X; Kawatsu Y; Kimura T; Horie S; Nabeshima A; Noguchi H; Wang KY; Sasaguri Y; Kohno K; Yamada S
    Tumour Biol; 2014 Oct; 35(10):10555-69. PubMed ID: 25060178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
    Liu XD; Zhang ZW; Wu HW; Liang ZY
    Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma.
    Huang Y; Ren GP; Xu C; Dong SF; Wang Y; Gan Y; Zhu L; Feng TY
    BMC Cancer; 2014 Jul; 14():479. PubMed ID: 24989027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis.
    Wang Y; Fang T; Huang L; Wang H; Zhang L; Wang Z; Cui Y
    Biochem Biophys Res Commun; 2018 Jun; 501(1):313-319. PubMed ID: 29738769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
    Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Yamaguchi A; Kuwai T; Sudo T; Hadano N; Tashiro H; Taniyama K; Yasuif W
    Histol Histopathol; 2022 Mar; 37(3):243-250. PubMed ID: 34821375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.
    Li J; Hu G; Kong F; Wu K; Song K; He J; Sun W
    Pathol Oncol Res; 2015 Sep; 21(4):1013-20. PubMed ID: 25791566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
    Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
    Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8
    Yamaki S; Yanagimoto H; Tsuta K; Ryota H; Kon M
    Int J Clin Oncol; 2017 Aug; 22(4):726-733. PubMed ID: 28314962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.